- Home
- TXMD vs CNC Comparison
TXMD vs CNC Comparison
Compare TXMD & CNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXMD
- CNC
- Stock Information
- Founded
- TXMD 2008
- CNC 1984
- Country
- TXMD United States
- CNC United States
- Employees
- TXMD N/A
- CNC N/A
- Industry
- TXMD Biotechnology: Pharmaceutical Preparations
- CNC Medical Specialities
- Sector
- TXMD Health Care
- CNC Health Care
- Exchange
- TXMD Nasdaq
- CNC Nasdaq
- Market Cap
- TXMD 12.8M
- CNC 28.1B
- IPO Year
- TXMD N/A
- CNC 2001
- Fundamental
- Price
- TXMD $1.18
- CNC $33.31
- Analyst Decision
- TXMD
- CNC Buy
- Analyst Count
- TXMD 0
- CNC 17
- Target Price
- TXMD N/A
- CNC $69.56
- AVG Volume (30 Days)
- TXMD 44.7K
- CNC 10.9M
- Earning Date
- TXMD 08-11-2025
- CNC 07-25-2025
- Dividend Yield
- TXMD N/A
- CNC N/A
- EPS Growth
- TXMD N/A
- CNC 33.19
- EPS
- TXMD N/A
- CNC 6.72
- Revenue
- TXMD $1,841,000.00
- CNC $153,266,000,000.00
- Revenue This Year
- TXMD $427.09
- CNC $23.54
- Revenue Next Year
- TXMD N/A
- CNC $0.60
- P/E Ratio
- TXMD N/A
- CNC $4.96
- Revenue Growth
- TXMD 53.55
- CNC 7.22
- 52 Week Low
- TXMD $0.70
- CNC $33.30
- 52 Week High
- TXMD $2.44
- CNC $80.59
- Technical
- Relative Strength Index (RSI)
- TXMD 48.98
- CNC 15.68
- Support Level
- TXMD $0.98
- CNC $53.19
- Resistance Level
- TXMD $1.21
- CNC $57.46
- Average True Range (ATR)
- TXMD 0.09
- CNC 1.56
- MACD
- TXMD 0.01
- CNC -1.86
- Stochastic Oscillator
- TXMD 80.00
- CNC 0.04
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
About CNC Centene Corporation
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.